Biggest News Aggregation in the World
📰 Leukemia News

Page 121 - Leukemia News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Venetoclax in addition to ibrutinib effective as a treatment for chronic lymphocytic leukemia

1. High genetic risk participants with chronic lymphocytic leukemia (CLL) taking venetoclax in addition to ibrutinib achieved high rates of achievement of undetectable measurable disease, very low risk of on-treatment disease progression, and durable off-treatment remissions. Evidence Rating Level: 2 (Good) Ibrutinib is an inhibitor of Bruton’s tyrosine kinase (BTK), and one of its indicated
Rating Level Hematology Oncology Chronic Disease

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science